Sera Prognostics, Inc. (SERA): who owns it and who trades it
As of Nov 16, 2026, SERA insiders reported 44 open-market sales worth $531K and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Zhenya Lindgardt (CEO), with $260K. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling SERA Prognostics
From the latest filingsOverall: more selling than buying. Funds and insiders mostly sold. Famous investors was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns SERA
45 funds and institutions reported SERA shares worth $31M at the end of Q2 2026. The largest holder is Baker Bros. Advisors LP with $10M.
10 largest owners, by value
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 5.50M | – | $10M | No change |
| Whetstone Capital Advisors, LLC | 3.31M | – | $6M | No change |
| Aberdeen Group plc | 2.75M | – | $5M | +8% |
| Vivo Capital, LLC | 1.65M | – | $3M | No change |
| Vanguard Capital Management LLC | 1.30M | – | $2.4M | +8% |
| Captrust Financial Advisors | 535,755 | – | $975K | -0% |
| Geode Capital Management, LLC | 348,967 | – | $635K | -4% |
| BlackRock, Inc. | 221,369 | – | $403K | +13% |
| AWM Investment Company, Inc. | 207,382 | – | $377K | No change |
| Vanguard Fiduciary Trust Co | 170,908 | – | $311K | +1% |
| State Street Corp | 124,792 | – | $227K | No change |
| Millennium Management LLC | 73,986 | – | $135K | -19% |
| Perigon Wealth Management, LLC | 72,685 | – | $132K | No change |
| Northern Trust Corp | 68,595 | – | $125K | -29% |
| Bank of New York Mellon Corp | 60,927 | – | $111K | No change |
| Bridgeway Capital Management, LLC | 55,705 | – | $101K | +22% |
| Requisite Capital Management, LLC | 55,648 | – | $101K | No change |
| Morgan Stanley | 50,972 | – | $92.8K | -51% |
| Qube Research & Technologies Ltd | 50,871 | – | $92.6K | +155% |
| Ballentine Partners, LLC | 49,664 | – | $90.4K | No change |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, SERA insiders reported $0 of open-market purchases and $531K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | Tiffany Eul Davis Inglis | Chief Medical Officer | Sale | 8,024 | $2.03 | $16.3K | Form 4 |
| Sep 10, 2026 | Dyaarl Lee Anderson Jr. | Chief Commercial Officer | Sale | 1,800 | $2.00 | $3.6K | Form 4 |
| Sep 10, 2026 | Zhenya Lindgardt | CEO | Sale | 7,022 | $2.00 | $14K | Form 4 |
| Sep 10, 2026 | Benjamin Jackson | General Counsel | Sale | 2,190 | $2.00 | $4.4K | Form 4 |
| Sep 10, 2026 | Tiffany Eul Davis Inglis | Chief Medical Officer | Sale | 486 | $2.00 | $972 | Form 4 |
| Sep 8, 2026 | Zhenya Lindgardt | CEO | Sale | 20,139 | $2.00 | $40.3K | Form 4 |
| Jun 11, 2026 | Dyaarl Lee Anderson Jr. | Chief Commercial Officer | Sale | 4,739 | $2.01 | $9.5K | Form 4 |
| Jun 11, 2026 | Austin Aerts | CFO | Sale | 2,037 | $2.01 | $4.1K | Form 4 |
| Jun 11, 2026 | Zhenya Lindgardt | CEO | Sale | 6,990 | $2.01 | $14K | Form 4 |
| Jun 11, 2026 | Tiffany Eul Davis Inglis | Chief Medical Officer | Sale | 362 | $2.01 | $728 | Form 4 |
| Jun 11, 2026 | Benjamin Jackson | General Counsel | Sale | 2,179 | $2.01 | $4.4K | Form 4 |
| Jun 9, 2026 | Zhenya Lindgardt | CEO | Sale | 20,755 | $2.08 | $43.2K | Form 4 |
| Jun 9, 2026 | Austin Aerts | CFO | Sale | 5,440 | $2.08 | $11.3K | Form 4 |
| Jun 8, 2026 | Sandra AJ Lawrence | Director | Sale | 1,560 | $2.15 | $3.4K | Form 4 |
| Mar 11, 2026 | Zhenya Lindgardt | CEO | Sale | 2,973 | $2.04 | $6.1K | Form 4 |
| Mar 11, 2026 | Paul Kearney | Chief Data Officer | Sale | 1,396 | $2.04 | $2.8K | Form 4 |
| Mar 11, 2026 | Benjamin Jackson | General Counsel | Sale | 1,027 | $2.04 | $2.1K | Form 4 |
| Mar 11, 2026 | Robert Gardner Harrison | Chief Information Office | Sale | 716 | $2.04 | $1.5K | Form 4 |
| Mar 11, 2026 | John J. Boniface | Chief Scientific Officer | Sale | 1,517 | $2.04 | $3.1K | Form 4 |
| Mar 11, 2026 | Austin Aerts | CFO | Sale | 1,019 | $2.04 | $2.1K | Form 4 |
| Mar 10, 2026 | Zhenya Lindgardt | CEO | Sale | 22,639 | $1.90 | $43K | Form 4 |
| Mar 10, 2026 | Austin Aerts | CFO | Sale | 6,069 | $1.90 | $11.5K | Form 4 |
| Mar 9, 2026 | Paul Kearney | Chief Data Officer | Sale | 2,026 | $1.96 | $4K | Form 4 |
| Mar 9, 2026 | Benjamin Jackson | General Counsel | Sale | 3,119 | $1.96 | $6.1K | Form 4 |
| Mar 9, 2026 | Robert Gardner Harrison | Chief Information Office | Sale | 3,360 | $1.96 | $6.6K | Form 4 |
| Mar 9, 2026 | John J. Boniface | Chief Scientific Officer | Sale | 3,038 | $1.96 | $6K | Form 4 |
| Mar 9, 2026 | Austin Aerts | CFO | Sale | 674 | $1.96 | $1.3K | Form 4 |
| Mar 6, 2026 | Sandra AJ Lawrence | Director | Sale | 1,560 | $1.95 | $3K | Form 4 |
| Feb 24, 2026 | Robert Gardner Harrison | Chief Information Office | Sale | 2,000 | $2.34 | $4.7K | Form 4 |
| Jan 27, 2026 | Robert Gardner Harrison | Chief Information Office | Sale | 2,000 | $2.97 | $5.9K | Form 4 |
| Dec 30, 2025 | Robert Gardner Harrison | Chief Information Office | Sale | 2,000 | $3.00 | $6K | Form 4 |
| Dec 10, 2025 | Zhenya Lindgardt | CEO | Sale | 4,155 | $3.31 | $13.8K | Form 4 |
| Dec 10, 2025 | Paul Kearney | Chief Data Officer | Sale | 1,213 | $3.31 | $4K | Form 4 |
| Dec 10, 2025 | Benjamin Jackson | General Counsel | Sale | 892 | $3.31 | $3K | Form 4 |
| Dec 10, 2025 | Robert Gardner Harrison | Chief Information Office | Sale | 616 | $3.31 | $2K | Form 4 |
| Dec 10, 2025 | John J. Boniface | Chief Scientific Officer | Sale | 1,332 | $3.31 | $4.4K | Form 4 |
| Dec 10, 2025 | Austin Aerts | CFO | Sale | 873 | $3.31 | $2.9K | Form 4 |
| Dec 9, 2025 | Zhenya Lindgardt | CEO | Sale | 28,215 | $3.04 | $85.8K | Form 4 |
| Dec 9, 2025 | Austin Aerts | CFO | Sale | 5,232 | $3.04 | $15.9K | Form 4 |
| Dec 8, 2025 | Sandra AJ Lawrence | Director | Sale | 1,560 | $3.05 | $4.8K | Form 4 |
| Dec 5, 2025 | Mansoor Raza Mirza | Director | Sale | 292 | $3.05 | $891 | Form 4 |
| Dec 2, 2025 | Robert Gardner Harrison | Chief Information Office | Sale | 2,000 | $2.93 | $5.9K | Form 4 |
| Dec 2, 2025 | Paul Kearney | Chief Data Officer | Sale | 32,203 | $2.94 | $94.7K | Form 4 |
| Nov 26, 2025 | Paul Kearney | Chief Data Officer | Sale | 1,986 | $3.51 | $7K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Zhenya Lindgardt | Chief Executive Officer, Director | – | $260K | Sep 10, 2026 |
| Paul Kearney | Chief Data Officer | – | $112K | Mar 11, 2026 |
| Austin Aerts | Chief Financial Officer | – | $49.1K | Jun 11, 2026 |
| Robert Gardner Harrison | Chief Information Officer | – | $32.6K | Mar 11, 2026 |
| Benjamin Jackson | General Counsel | – | $19.9K | Sep 10, 2026 |
| Tiffany Eul Davis Inglis | Chief Medical Officer | – | $18K | Oct 12, 2026 |
| John J. Boniface | Chief Scientific Officer | – | $13.5K | Mar 11, 2026 |
| Dyaarl Lee Anderson Jr. | Chief Commercial Officer | – | $13.1K | Sep 10, 2026 |
| Sandra AJ Lawrence | Director | – | $11.2K | Jun 8, 2026 |
| Mansoor Raza Mirza | Director | – | $891 | Dec 5, 2025 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
SERA short interest
219,751 SERA shares are sold short. Over the last 12 reports the number of shares short went down 22%.
As of Oct 30, 2026, 219,751 SERA shares were sold short, down 1.3% from the report before. At the average daily volume of 24,089 shares, buying them all back would take about 9.1 trading days (days to cover).
Shares short
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 219,751 | – | -1% | 24,089 | 9.1 |
| Oct 15, 2026 | 222,706 | – | -3% | 10,341 | 21.5 |
| Sep 30, 2026 | 229,723 | – | +7% | 17,119 | 13.4 |
| Sep 15, 2026 | 213,893 | – | -4% | 28,325 | 7.5 |
| Aug 31, 2026 | 221,791 | – | -2% | 21,234 | 10.4 |
| Aug 14, 2026 | 225,264 | – | -2% | 37,541 | 6.0 |
| Jul 31, 2026 | 230,875 | – | -4% | 35,921 | 6.4 |
| Jul 15, 2026 | 240,837 | – | -8% | 35,282 | 6.8 |
| Jun 30, 2026 | 262,549 | – | -1% | 40,703 | 6.5 |
| Jun 15, 2026 | 265,259 | – | -11% | 50,590 | 5.2 |
| May 29, 2026 | 297,212 | – | +6% | 94,780 | 3.1 |
| May 15, 2026 | 280,984 | – | -6% | 67,186 | 4.2 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
SERA Prognostics company events
SERA Prognostics filed 11 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership). The latest was on Nov 4, 2026.
- Nov 4, 2026ResultsReleased financial results. Filing
- Aug 19, 2026LeadershipThe Board of Directors appointed Scott Gleason to serve as the next Chief Financial Officer and Treasurer of Sera Prognostics, Inc., effective August 31, 2026, pursuant to the planned transition described below. Filing
- Aug 12, 2026ResultsReleased financial results. Filing
- Jun 30, 2026LeadershipUpon the recommendation of the Nominating and Governance Committee of the Board of Directors of Sera Prognostics, Inc., and pursuant to the Amended and Restated Bylaws of the Company, the Board appointed, effective as of July 1, 2026, Mark Capone to serve as a Class II director, with an initial… Filing
- Jun 4, 2026VoteReported shareholder vote results. Filing
- Jun 1, 2026LeadershipJeffrey T. Elliott, a member of the Board of Directors of Sera Prognostics, Inc., notified the Company of his decision to resign from the Board effective as of June 4, 2026, the date of the Company’s Annual Stockholders Meeting. Filing
- May 6, 2026ResultsReleased financial results. Filing
- Mar 18, 2026ResultsReleased financial results. Filing
- Jan 8, 2026AnnouncementShared information with investors. Filing
- Jan 7, 2026AnnouncementShared information with investors. Filing
- Nov 24, 2025AnnouncementShared information with investors. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
SERA Prognostics financials
Famous investors that hold SERA
2 of the 50 well-known investors we track reported holding SERA in their latest 13F filing. The largest position is Israel Englander's, worth $129K.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 61,949 | $129K | 0.0% | -16% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 50,271 | $105K | 0.0% | +21% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Sera Prognostics, Inc. (SERA) stock
Who owns the most SERA stock?
The largest reported owner of Sera Prognostics, Inc. (SERA) is Baker Bros. Advisors LP. In total, 45 funds and institutions reported holding SERA at the end of Q2 2026. See the largest owners.
Are SERA insiders buying or selling?
In the last 12 months, SERA insiders reported no open-market purchases and 44 sales worth $531K. The latest trade was on Oct 12, 2026. See every trade.
What is the short interest in SERA?
As of Oct 30, 2026, 219,751 SERA shares were sold short, down 1.3% from the report before. At the average daily volume of 24,089 shares, buying them all back would take about 9.1 trading days (days to cover). See the history.
Which famous investors hold SERA?
2 of the 50 well-known investors we track reported SERA in their latest 13F filing, including Israel Englander, Ken Griffin. The largest position is worth $129K. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.